Skip to main
UHS
UHS logo

UHS Stock Forecast & Price Target

UHS Analyst Ratings

Based on 33 analyst ratings
Buy
Strong Buy 33%
Buy 21%
Hold 36%
Sell 9%
Strong Sell 0%

Bulls say

Universal Health Services Inc. has demonstrated strong financial performance, with Acute Same-Store revenues increasing by 8.7% year-over-year, indicating robust demand within the Acute Care Hospital Services segment. Additionally, the Behavioral Health segment's EBITDA exceeded projections by 11%, driven by a notable 11.1% growth in same-store revenues, reflecting effective operational management and demand growth. The company's overall adjusted admissions growth further supports a favorable outlook, as it reported a 5.3% increase, signifying a strengthening trajectory in patient volume and service utilization.

Bears say

The financial analysis reveals a concerning trend in Universal Health Services Inc.'s revenue generation, with a dominant reliance on its Acute Care Hospital Services segment, which has faced increasing operational costs and declining patient volumes. Additionally, challenges in the Behavioral Health Services segment, including regulatory pressures and reimbursement rate adjustments, further compound the company's financial strain. Overall, these factors contribute to an unfavorable outlook for the firm's stock performance as they signal potential difficulties in sustaining profitability in the near term.

UHS has been analyzed by 33 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 21% recommend Buy, 36% suggest Holding, 9% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Universal Health Services and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Universal Health Services (UHS) Forecast

Analysts have given UHS a Buy based on their latest research and market trends.

According to 33 analysts, UHS has a Buy consensus rating as of Jul 23, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $161.79, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $161.79, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Universal Health Services (UHS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.